CYP2C19
Pharmacist assessment of drug-gene interactions and drug-induced phenoconversion in major depressive disorder: A Case Report
Del Toro-Pagán NM, Matos A, Bardolia C, Michaud V, Turgeon J, Amin NS Published 1/20/2022 Abstract Background Response to antidepressant therapy is highly variable among individuals. Pharmacogenomic (PGx) testing presents an opportunity to guide drug selection while optimizing therapy [...]